Kinase insert domain receptor

From WikiMD's Food, Medicine & Wellness Encyclopedia

Kinase insert domain receptor (KDR), also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a vascular endothelial growth factor (VEGF) receptor. KDR is a type of receptor tyrosine kinase (RTK) that is predominantly expressed in endothelial cells and plays a crucial role in angiogenesis and vasculogenesis.

Structure[edit | edit source]

The KDR protein is a transmembrane receptor composed of seven immunoglobulin-like domains in the extracellular domain, a single transmembrane spanning region, and a cytoplasmic tyrosine kinase domain split by a kinase-insert domain. The kinase insert domain is unique to KDR and other related receptors, hence the name "kinase insert domain receptor".

Function[edit | edit source]

KDR is a key mediator of VEGF-induced endothelial proliferation, survival, and migration and tubulogenesis. It is also a cellular receptor for macrophage-stimulating protein (MSP) which upon binding induces its dimerization and autophosphorylation.

Clinical significance[edit | edit source]

Mutations in KDR gene are associated with infantile capillary hemangiomas. In addition, KDR/VEGFR-2 is a major target for anti-angiogenic drug therapy in cancer treatment.

See also[edit | edit source]

References[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD